Drug
Broncho Vaxom
Broncho Vaxom: highest development phase Phase 3, developed by Vifor Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Vifor Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Broncho-Vaxom NCT03047954 | Phase 3 | Atopic Dermatitis |
Latest
No recent events.
Follow Broncho Vaxom on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.